At Alfie, we've built a program based on the top research from places like Harvard and Stanford that allows us to precisely determine which weight loss medications will be most effective for our members in a multimodal approach. We're optimizing medications in complex care pathways like no one else has before.

Our program has been shown to be 2x more effective than standard prescription medication and 5x more effective than habit change alone.

We've raised seed capital from firms like Goodwater Capital, Nina Capital, and Pheonix Club, and various angels including the founder of OpenTrons (raised $200M from Softbank).